Transcriptional Fingerprinting meets Drug Discovery


Transcriptional Fingerprinting meets Drug Discovery


Transcriptional Fingerprinting meets Drug Discovery

Mission


 

QUANTRO will combine and exploit innovative technologies in the areas of functional-genetics and transcriptomics to generate an unprecedented cancer drug discovery pipeline transforming the precision and scope of cell-based compound screens.

Read more about the Company & Our Science.

June 04, 2024

QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments

ENDE
 
 
Contact

Job Offers

QUANTRO Therapeutics GmbH
Dr. Bohr-Gasse 7
A-1030 Vienna, Austria

+43 122 66001

© 2023 QUANTRO Therapeutics GmbH